The Gold Trade, May 24
Health Care: Drugs
Neuralstem Inc. (CUR: AMEX)
$1.42 -0.02 | -1.39%
05/24/13 - 01:13 PM ET
Latest Dividend:0.00
Latest Dividend Yield:0.00%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:n/a
Price Earnings Comparisons:
| CUR | Sector Avg. | S&P 500 |
|---|---|---|
| n/a | 0.00 | 17.70 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| 24.35 | 60.00 | -48.38 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | 4.40 | 0.00 | 0.00 |
| Net Income | 0.00 | 0.00 | |
| EPS | -0.43 | 0.00 |
Earnings for CUR:
| EBITDA | -9.00 |
| REVENUE | 407.71K |
Average Earnings Estimates
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $-0.04 | $-0.04 | $-0.16 | $-0.14 |
| Number of Analysts | 1 | 1 | 1 | 1 |
| High Estimate | $-0.04 | $-0.04 | $-0.16 | $-0.14 |
| Low Estimate | $-0.04 | $-0.04 | $-0.16 | $-0.14 |
| Prior Year | $-0.04 | $-0.04 | $-0.17 | $-0.16 |
| Growth Rate (Year over Year) | 0.00% | 0.00% | 5.88% | 12.50% |
Portfolios with CUR
- Portfolio NameUser Type
- Userdennis diamonds
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- Usermine
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- UserBio
- Userjustin
- ContributorBreakout Stocks Of The Week...
Latest CUR Headlines from TheStreet
- 4 Biotech Stocks Under $10 Moving Higher 11.27.12 | 02:11 pm
- 4 Biotech Stocks Under $10 Moving Higher 10.05.12 | 08:10 am
- Stocks Close Week Higher on QE3 Confidence 09.14.12 | 05:09 pm
- 5 Stocks Under $10 Setting Up to Break Out 09.13.12 | 12:09 pm
- 5 Stocks Poised for Big Breakouts 08.31.12 | 01:08 pm
- 9 Biotech Penny Stocks to Buy 08.31.10 | 10:08 am
- Interstate Hotel, Neuralstem: Midday Volume Plays 12.18.09 | 01:12 pm
- Four Must-See Charts: Stem Cell Stocks 07.02.09 | 03:07 pm
- Stem cell firms jump on Obama policy plans 03.06.09 | 06:03 pm
- Wednesday's Health Winners & Losers 09.19.07 | 04:09 pm
Press Releases for CUR
- Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania - PR Newswire 05.20.13 | 09:05 am
- Neuralstem CEO, Richard Garr, To Present At Annual World Stem Cells And Regenerative Medicine Congress In London - PR Newswire 05.16.13 | 09:05 am
- DiagnoCure Announces Presentation On Previstage GCC At The 2013 ASCO Annual Meeting - PR Newswire 05.16.13 | 07:05 am
- Neuralstem Principal Investigator, Dr. Eva Feldman, Presents Phase I ALS Trial Data At The Romanian Neurological Society Congress - PR Newswire 05.13.13 | 09:05 am
- Neuralstem ALS Trial Investigator And Patient On Sirius XM - PR Newswire 05.08.13 | 09:05 am
- Neuralstem ALS Trial Data Presented At The American Association Of Neurological Surgeons Annual Meeting - PR Newswire 04.29.13 | 11:04 am
- DiagnoCure's Update Presentation During The Annual And Special Meeting Of Shareholders - PR Newswire 04.29.13 | 07:04 am
- Neuralstem And The National Football League Alumni Association Announce Initiative On Brain Injury Treatment - PR Newswire 04.24.13 | 09:04 am
- FDA Approves Neuralstem To Treat Final Cohort In NSI-189 Phase Ib Trial In Major Depressive Disorder - PR Newswire 04.22.13 | 09:04 am
- Neuralstem CEO, Richard Garr, To Participate In Traumatic Brain Injury Panel At BIO International Convention - PR Newswire 04.18.13 | 09:04 am
Partner Headlines for CUR
- Brainstorm's Breakthrough ALS Clinical Data Shows The Promise In Stem Cell Therapy - Seeking Alpha 03.28.13 | 09:03 am
- 3 Regenerative Medicine Companies That Could Deliver In 2013 - Seeking Alpha 01.22.13 | 09:01 am
- Biotech Under The Electron Microscope: What's In The Pipeline And Lessons To Be Learned - Seeking Alpha 12.16.12 | 08:12 am
- Neuralstem Swinging For The ALS Fences - Seeking Alpha 10.29.12 | 09:10 am
- 4 Biotechs That Just Got Mauled By Bears - Seeking Alpha 10.10.12 | 09:10 am
- Morning Market Movers - Benzinga 10.04.12 | 09:10 am
- Dr. Eva Feldman, Principal Investigator, To Update Interim Data On Neuralstem ALS Trial - Benzinga 10.04.12 | 09:10 am
- Neuralstem Grants First Licenses for CNS Therapy Surgical Devices - Benzinga 09.06.12 | 09:09 am
- ALS Patient's Survival is "One of the Most Powerful Stories" Ever Reported - Benzinga 08.27.12 | 01:08 pm
- End-of-Day Market Summary for November 23, 2011 - Benzinga 11.23.11 | 04:11 pm
